+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05637294

Evaluating Night-time and Full-time Wrist Splinting Versus No Treatment for Carpal Tunnel Syndrome in a Randomized Crossover Trial

Led by Tampere University Hospital · Updated on 2026-10-05

110

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Carpal tunnel syndrome is a common nerve compression disorder in the upper limbs causing pain, numbness, and tingling in the fingers, often worse at night. The FINCROSS trial is a randomized crossover study that evaluates the effects of night-time and full-time wrist splinting compared to no treatment. It also aims to identify which patients might benefit most from splinting and whether a positive response reduces the need for surgery. Participants will undergo three treatment periods in random order wearing a wrist splint at night for six weeks, wearing the splint day and night for six weeks, and a six-week period without treatment. Each treatment phase is separated by a three-week washout period, making the full sequence 24 weeks long. Participants will also perform self-administered wrist stretching exercises throughout the study and avoid other medical interventions. During the study, participants will be assessed using symptom scales such as the 6-item CTS Symptoms Scale and the Boston Carpal Tunnel Questionnaire at baseline, mid-treatment, end of each treatment, and one year after randomization. Researchers will monitor symptom changes, quality of life, adverse effects, need for surgery, and use of escape treatments. Follow-up continues up to one year after starting the study.

CONDITIONS

Brief Title

Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome

Research Team

V

Vieda Lusa

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here